Human papillomavirus;Cervical intraepithelial lesion;Colposcopy;Biopsy;Cervical cancer screening;ThinPrep cytologic test," />
人乳头瘤病毒,宫颈上皮内瘤变,阴道镜,活检,宫颈癌筛查,液基细胞学,"/>
Human papillomavirus;Cervical intraepithelial lesion;Colposcopy;Biopsy;Cervical cancer screening;ThinPrep cytologic test,"/>
Retrospective analysis of colposcopy biopsy results in 871 cases of human papillomavirus 16/18 positive patients
<div> </div>
Retrospective analysis of colposcopy biopsy results in 871 cases of human papillomavirus 16/18 positive patients
YU Gui-yuan1 CHEN Min-jie2 MIN Qing-hua3 HE Shu-fang3▲
1.Department of Anesthesiology,the First Affiliated Hospital of Nanchang University,Jiangxi Province,Nanchang 330006,China;2.Department of Clinical Medicine,Queen Mary College,Nanchang University,Jiangxi Province,Nanchang 330006,China;3.Department of Obstetrics and Gynecology,the First Affiliated Hospital of Nanchang University,Jiangxi Province,Nanchang 330006,China
AbstractObjective To retrospectively analyze the results of ThinPrep cytologic test (TCT) and colposcopy biopsy of human papillomavirus (HPV) 16/18 positive patients,and to explore the value of using HPV16/18 partial typing in the early diagnosis of cervical lesions.Methods Altogether 871 cases of HPV16/18 positive patients who were referred for colposcopy biopsy in the Department of Obstetrics and Gynecology,the First Affiliated Hospital of Nanchang University from January 2016 to January 2018 were collected,and their age,TCT,HPV and the pathological results were collected for statistical analysis.Results Of all the 871 patients included in this study,469 cases (53.8%) were cervical inflammation,111 cases (12.7%) were cervical intraepithelial neoplasia 1 (CIN1),84 cases (9.6%) were CIN2,124 cases(14.2%) were CIN3,and 83 cases (9.5%) were cervical cancer.The HPV16/18 positive patients were subgrouped into 21-30,>30-40,>40-50,and >50 years old,and the proportions of CIN2+lesions were 19.1% (31/162) and 28.4% (64/225),39.1% (109/279),42.4% (87/205),respectively.Among the HPV16/18 positive and menopausal patients,the detection rate of CIN2+lesions was higher than that of non-menopausal patients (40.4% vs.30.7%),and the difference was statistically significant (χ2=7.31,P<0.01).Conclusion The detection rate of CIN2+lesions in HPV16/18 positive patients is about 33.4%,and with the increase of age,the detection rate of CIN2+tends to increase gradually.The immediate transfer of patients to colposcopy whose HPV16/18 shows positive is very helpful to the early detection of cervical lesions.
E-mail this article
Human papillomavirus;Cervical intraepithelial lesion;Colposcopy;Biopsy;Cervical cancer screening;ThinPrep cytologic test”. Please open it by linking:https://www.dangdaiyiyao.com/EN/abstract/abstract13500.shtml" name="neirong">
Huh WK，Auh KA，Chelmow D，et al.Use of primary high-risk human papillomavirus testing for cervical cancer screening：interim clinical guidance[J].Gynecol Oncol，2015，136（2）：178-182.
Wright TC，Stoler MH，B ehrens CM，et al.Primary cervical cancer screening with human papillomavirus：End of study results from the ATHENA study using HPV as the first-line screening test[J].Gynecol Oncol，2015，136（2）：189-197.
Huh WK，Williams E，Huang J，et al.Cost effectiveness of human papillomavirus 16/18 genotyping in cervical cancer screening[J].Appl Health Econ Health Policy，2015，13（1）：95-107.
[12]
Arbyn M，Rezhake R，Yuill S，et al.Triage of HPV-positive women in Norway using cytology，HPV16/18 genotyping and HPV persistence[J].Brit J Cancer，2020，122(11)：1577-1579.
[13]
Kares S，Veijalainen O，Kholová I，et al.HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer：the value of HPV16 and HPV18 genotyping?[J].APMIS，2019，127（11）：710-716.
Wu Q，Zhao X，Fu Y，et al.A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11，064 Chinese women[J].Cancer Med，2017，6（5）：1091-1101.
[18]
Rodríguez AC，Schiffman M，Herrero R，et al.Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections[J].J Natl Cancer Inst，2008，100（7）：513-517.
